Premixed insulin aspart 30 (BIAsp 30) versus premixed human insulin 30 (BHI 30) in gestational diabetes mellitus: a randomized open-label controlled study.

Add to Collection

2012 Jul Others V Balaji, MS Balaji, C Alexander… - Gynecological …, 2012 - Taylor & Francis 111

Full Author : ['Balaji, Vijayam', 'Balaji, Madhuri S', 'Alexander, Cynthia', 'Srinivasan, Ashalata', 'Suganthi, Sheela R', 'Thiyagarajah, Arthi', 'Seshiah, Veerasamy']
Journal Title : Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology
Chapter : Section3
Journal Year : 2012
Cited by : 50.0

A randomized, open-label, parallel study was conducted to assess the efficacy and safety of premixed insulin aspart 30 (biphasic insulin aspart [BIAsp] 30) in managing gestational diabetes mellitus (GDM). A total of 323 women with GDM registered at a sing..... Read More

Keywords : ["premixed insulin aspart biasp versus premixed human insulin bhi", "randomize openlabel control study", "gestational diabetes mellitus"]
PubMed Link : https://www.tandfonline.com/doi/abs/10.3109/09513590.2011.650661
Google Scholar Link : https://scholar.google.com/scholar?cites=9278827714339271801&as_sdt=2005&sciodt=0,5&hl=en&num=20

Have a Question?

Premixed insulin aspart 30 (BIAsp 30) versus premixed human insulin 30 (BHI 30) in gestational diabetes mellitus: a randomized open-label controlled study.